Novartis issues recall on Excedrin, Bufferin
(Reuters) – The U.S. unit of Novartis AG on Sunday issued a nationwide recall of certain bottled versions of Excedrin and Bufferin, and two other products, because they may contain stray, broken or chipped tablets from other Novartis products. Nov…
View full post on Yahoo! Health News
Bufferin, Excedrin, issues, Novartis, recall